Key result
Cochrane protocol targets prognostic performance of the non-laboratory WHO 10-year CVD risk model.
Why the study?
The prognostic performance, including discrimination, calibration, and clinical applicability, of the World Health Organization non-laboratory-based 10-year CVD risk prediction models requires evaluation in external and internal validation studies.
What is the external prognostic performance (calibration and discrimination) of the WHO non-laboratory-based 10-year CVD risk prediction model in adults aged 40-74 years without established cardiovascular disease?
Systematic Review
What is the external prognostic performance (calibration and discrimination) of the WHO non-laboratory-based 10-year CVD risk prediction model in adults aged 40-74 years without established cardiovascular disease?
This Cochrane systematic review protocol outlines the methodology to evaluate the external calibration and discrimination of the WHO non-laboratory-based 10-year CVD risk model to inform WHO guidelines on primary prevention in resource-limited settings.
Answers are grounded in this paper and cite their sources.
Protocol for WHO non-lab CVD risk model validation may inform primary prevention in low-resource settings; leaves open its discrimination and calibration pending synthesis.
OBJECTIVES: This is a protocol for a Cochrane review (prognosis). The objectives are as follows: The objective of this review is to evaluate the prognostic performance of the World Health Organization (WHO) non-laboratory-based CVD risk prediction models in adults aged 40 years to 74 years without established CVD. To do this, we will assess the discrimination, calibration, and clinical applicability of the models in external and internal validation studies. Population Adults aged 40-74 years without established CVD, in primary prevention settings. Index prognostic model The WHO non-laboratory-based 10-year CVD risk prediction model, which estimates future cardiovascular risk using demographic and clinical predictors without requiring laboratory measurements. Comparator No comparator is required, as this review evaluates the external predictive performance of the WHO non-laboratory-based 10-year CVD risk prediction model rather than comparing different prediction models. Outcomes Calibration and discrimination of 10-year CVD risk. Timing Risk prediction is performed at baseline using the WHO non-laboratory-based model, with outcomes predicted over a 10-year time horizon. Setting Primary prevention and routine care settings, including resource-limited contexts where laboratory-based cardiovascular risk assessment is not readily available.
No takes yet. Share an insight, caveat, or question.
Olfati et al. (2026) conducted a systematic review in Primary prevention of cardiovascular disease. World Health Organization (WHO) non-laboratory-based 10-year CVD risk prediction model (including original 2007 WHO/ISH risk charts and 2019 updated WHO models) was evaluated on Prognostic performance (calibration and discrimination) for predicting 10-year fatal and non-fatal cardiovascular disease events. The WHO non-laboratory-based 10-year CVD risk prediction model will be evaluated for discrimination and calibration in adults aged 40-74 without established CVD in this Cochrane review protocol.
Synapse has enriched 10 related papers. Consider them for comparative context: